Mechanisms of Preconditioning Exercise-Induced Neurovascular Protection in Stroke

Ischemic stroke is a leading cause of death and disability. Tissue plasminogen activator is the only U.S. Food and Drug Administration approved thrombolytic therapy for ischemic stroke patients till date. However, its use is limited due to increased risk of bleeding and narrow therapeutic window. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafez, Sherif, Eid, Zeina, Alabasi, Sara, Darwiche, Yasenya, Channaoui, Sara, Hess, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521252/
https://www.ncbi.nlm.nih.gov/pubmed/34649377
http://dx.doi.org/10.5853/jos.2020.03006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521252/
https://www.ncbi.nlm.nih.gov/pubmed/34649377
http://dx.doi.org/10.5853/jos.2020.03006

Ejemplares similares